F, F., A, Z., R, L., A, P., M, S., U, T., & E, N. (2025). Type 2 diabetic disease and current drug treatments: Clinical and governance aspects. Endocrine, 89(1), 111. https://doi.org/10.1007/s12020-025-04263-2
Chicago Style (17th ed.) CitationF, Ferrara, Zovi A, Langella R, Panico A, Scognamiglio M, Trama U, and Nava E. "Type 2 Diabetic Disease and Current Drug Treatments: Clinical and Governance Aspects." Endocrine 89, no. 1 (2025): 111. https://doi.org/10.1007/s12020-025-04263-2.
MLA (9th ed.) CitationF, Ferrara, et al. "Type 2 Diabetic Disease and Current Drug Treatments: Clinical and Governance Aspects." Endocrine, vol. 89, no. 1, 2025, p. 111, https://doi.org/10.1007/s12020-025-04263-2.
Warning: These citations may not always be 100% accurate.